Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Experimental Physiology 89.6 pp 753-765
DOI: 10.1113/expphysiol.2004.028621
© The Physiological Society 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
89/6/753    most recent
expphysiol.2004.028621v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marissal-Arvy, N.
Right arrow Articles by Mormède, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marissal-Arvy, N.
Right arrow Articles by Mormède, P.
Related Collections
Right arrow Neuroendocrinology/Endocrinology

Excretion of electrolytes in Brown Norway and Fischer 344 rats: effects of adrenalectomy and of mineralocorticoid and glucocorticoid receptor ligands

Nathalie Marissal-Arvy1 and Pierre Mormède1

1 Neurogénétique et Stress, INSERM U471 - INRA UMR1243 - Université de Bordeaux 2, Institut François Magendie de Neurosciences, 1, rue Camille Saint Saëns, 33077 Bordeaux Cedex, France

Our previous studies showed that adrenalectomy (ADX) has surprisingly no effect on body weight and fluid intake in the Brown Norway rat strain, suggesting that mineralocorticoid receptor (MR)-mediated effects are present even in absence of corticosteroids in this strain. Moreover, glucocorticoid receptor (GR)-mediated mechanisms are more effective in Brown Norway than in Fischer 344 rats. Such functional differences in corticosteroid receptor pathways between Brown Norway and Fischer 344 rats led us to compare the effect of ADX and MR/GR-mediated actions on sodium and potassium excretion between these two rat strains. To this end, we first measured the effect of an acute high dose of aldosterone on the urinary Na+/K+ concentration ratio in intact and ADX Brown Norway and Fischer 344 rats. Second, to discriminate mineralocorticoid from glucocorticoid actions, we treated chronically ADX rats with increasing doses of aldosterone or RU28362, a pure GR agonist, in the drinking fluid. As sodium homeostasis involves salt appetite regulation, behaviour under mineralocorticoid control, we also measured saline preference in Brown Norway and Fischer 344 rats. Our data illustrate: (1) the very limited effect of ADX on body weight, food and fluid intake, diuresis, natriuresis, kaliuresis and salt appetite in Brown Norway rats, supporting the presence of MR signalling pathways in the absence of adrenal steroids in these rats; (2) the insensitivity of MR to aldosterone in intact Brown Norway rats, and the reduced sensitivity of MR to aldosterone in ADX Brown Norway rats compared with ADX Fischer 344 rats; and (3) the greater sensitivity of GR-related mechanisms to RU28362 in Brown Norway than in Fischer 344 rats in terms of body weight gain and electrolyte excretion. Considering that both MRs and GRs regulate hypothalamic–pituitary–adrenal axis processes, such functional differences in corticosteroid receptors could be at the origin, at least partly, of the strain differences in corticotropic activity/reactivity to stress previously described.

(Received 8 July 2004; accepted after revision 9 September 2004; first published online 13 September 2004)
Corresponding author Nathalie Marissal-Arvy: INSERM U471 - INRA UMR1243 - Université de Bordeaux 2, Institut François Magendie de Neurosciences, 1, rue Camille Saint Saëns, 33077 Bordeaux Cedex, France. Email: marissal{at}bordeaux.inserm.fr




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
J. E. Goodwin, J. Zhang, and D. S. Geller
A Critical Role for Vascular Smooth Muscle in Acute Glucocorticoid-Induced Hypertension
J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1291 - 1299.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Pascual-Le Tallec and M. Lombes
The Mineralocorticoid Receptor: A Journey Exploring Its Diversity and Specificity of Action
Mol. Endocrinol., September 1, 2005; 19(9): 2211 - 2221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
V. Vallon, D. Y. Huang, F. Grahammer, A. W. Wyatt, H. Osswald, P. Wulff, D. Kuhl, and F. Lang
SGK1 as a determinant of kidney function and salt intake in response to mineralocorticoid excess
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R395 - R401.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the The Physiological Society.